Education
About Us
Working with TipRanks
Follow Us
Idexx Laboratories (IDXX)
NASDAQ:IDXX
IDXX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$356.14 - $548.88
Previous CloseN/A
Volume277.29K
Average Volume (3M)1.05M
Market Cap
$38.10B
Enterprise Value$35.30B
Total Cash (Recent Filing)$163.97M
Total Debt (Recent Filing)$1.06B
Price to Earnings (P/E)43.8
Beta1.09
Next Earnings
Aug 05, 2025EPS Estimate
3.27Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.96
Shares Outstanding80,421,920
10 Day Avg. Volume1,039,282
30 Day Avg. Volume1,046,606
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.93
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda27.30
Forecast
1Y Price Target
$508.83Price Target Upside4.57% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceFirst-quarter sales are in line with consensus while EPS are about 4% above Street expectations.
InnovationInitial interest in Cancer Dx has been promising, and the reiterated guide of 4.5K InVue Dx placements this year is encouraging.
Revenue GrowthIDEXX expects to deliver over one point of revenue growth from its new InVueDx system and place 4,500 systems this year alone.
Bears Say
Macroeconomic ChallengesAnimal Health sentiment remains cautious due to challenged macroeconomic conditions and veterinary visit concerns.
Market ConditionsPersistent end-market weakness might raise questions as to how the company can reach its reiterated guidance ranges.
Veterinary VisitsVeterinary office visits have been declining for the past 13 consecutive quarters in the US, impacting CAG growth.
---
Ownership Overview
0.98% Insiders
25.54% Mutual Funds
1.03% Other Institutional Investors
41.42% Public Companies and
Individual Investors
IDXX FAQ
What was Idexx Laboratories’s price range in the past 12 months?
Idexx Laboratories lowest stock price was $356.14 and its highest was $548.88 in the past 12 months.
What is Idexx Laboratories’s market cap?
Idexx Laboratories’s market cap is $38.10B.
When is Idexx Laboratories’s upcoming earnings report date?
Idexx Laboratories’s upcoming earnings report date is Aug 05, 2025 which is in 88 days.
How were Idexx Laboratories’s earnings last quarter?
Idexx Laboratories released its earnings results on May 01, 2025. The company reported $2.96 earnings per share for the quarter, beating the consensus estimate of $2.848 by $0.112.
Is Idexx Laboratories overvalued?
According to Wall Street analysts Idexx Laboratories’s price is currently Undervalued.
Does Idexx Laboratories pay dividends?
Idexx Laboratories does not currently pay dividends.
What is Idexx Laboratories’s EPS estimate?
Idexx Laboratories’s EPS estimate is 3.27.
How many shares outstanding does Idexx Laboratories have?
Idexx Laboratories has 80,421,920 shares outstanding.
What happened to Idexx Laboratories’s price movement after its last earnings report?
Idexx Laboratories reported an EPS of $2.96 in its last earnings report, beating expectations of $2.848. Following the earnings report the stock price went up 8.952%.
Which hedge fund is a major shareholder of Idexx Laboratories?
Currently, no hedge funds are holding shares in IDXX
---
Idexx Laboratories Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$508.83 (4.57% Upside)
$508.83 (4.57% Upside)
Blogger Sentiment
Bullish
IDXX Sentiment 75%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 62.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $6.0M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.2%
Last 30 Days ▼ 3.9%
Last 30 Days ▼ 3.9%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-0.66%
12-Months-Change
Fundamentals
Return on Equity
59.33%
Trailing 12-Months
Asset Growth
-4.17%
Trailing 12-Months
Company Description
Idexx Laboratories
IDEXX Laboratories, Inc. is a global leader in veterinary diagnostics, software, and water microbiology testing. Headquartered in Westbrook, Maine, the company serves the veterinary, livestock, and poultry industries, as well as the water testing and dairy markets. IDEXX is renowned for its comprehensive diagnostics solutions, including laboratory services, point-of-care analyzers, and practice management software, aimed at enhancing animal health and ensuring public safety.
---
IDXX Company Deck
---
IDXX Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a generally positive sentiment with strong revenue growth, successful product launches, and significant international expansion. However, there are challenges, including a decline in U.S. clinical visits and pressures from the macroeconomic and trade environment.Read More>---
IDXX Revenue Breakdown
71.06% Americas
20.70% EMEA
8.24% APAC
---
IDXX Stock 12 Month Forecast
Average Price Target
$508.83
▲(4.57% Upside)
Technical Analysis
---